$TGTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TG THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TG THERAPEUTICS, INC.. Get notifications about new insider transactions in TG THERAPEUTICS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Director | Grant | A | 0.00 | 20,000 | 0 | 149,116 | 129.1 K to 149.1 K (+15.49 %) |
| Jun 22 2021 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 40,000 | 0 | 220,997 | 181 K to 221 K (+22.10 %) |
| Jun 22 2021 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 20,000 | 0 | 180,997 | 161 K to 181 K (+12.42 %) |
| Jan 04 2021 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 20,000 | 0 | 653,338 | 633.3 K to 653.3 K (+3.16 %) |
| Sep 11 2020 | TGTX | TG THERAPEUTICS, I ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | S | 25.81 | 158,589 | 4,092,738 | 12,629,868 | 12.8 M to 12.6 M (-1.24 %) |
| Jul 20 2020 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 200,000 | 0 | 633,338 | 433.3 K to 633.3 K (+46.15 %) |
| Jul 20 2020 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 50,000 | 0 | 433,338 | 383.3 K to 433.3 K (+13.04 %) |
| Jul 02 2020 | TGTX | TG THERAPEUTICS, I ... | Lonial Sagar | Director | Grant | A | 0.00 | 65,000 | 0 | 65,000 | 0 to 65 K |
| Jun 24 2020 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Grant | A | 0.00 | 1,556,029 | 0 | 14,434,214 | 12.9 M to 14.4 M (+12.08 %) |
| Jun 24 2020 | TGTX | TG THERAPEUTICS, I ... | HUME DANIEL | Director | Grant | A | 0.00 | 15,000 | 0 | 134,507 | 119.5 K to 134.5 K (+12.55 %) |
| Jun 24 2020 | TGTX | TG THERAPEUTICS, I ... | Hoberman Kenneth | Director | Grant | A | 0.00 | 15,000 | 0 | 158,953 | 144 K to 159 K (+10.42 %) |
| Jun 24 2020 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Director | Grant | A | 0.00 | 15,000 | 0 | 159,116 | 144.1 K to 159.1 K (+10.41 %) |
| Jun 24 2020 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 15,000 | 0 | 160,997 | 146 K to 161 K (+10.27 %) |
| Jun 24 2020 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Grant | A | 0.00 | 15,000 | 0 | 109,633 | 124.6 K to 109.6 K (-12.04 %) |
| Jun 24 2020 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Sell | S | 18.27 | 7,745 | 141,501 | 94,633 | 102.4 K to 94.6 K (-7.57 %) |
| Sep 18 2019 | TGTX | TG THERAPEUTICS, I ... | Hoberman Kenneth | Grant | A | 0.00 | 27,048 | 0 | 143,953 | 116.9 K to 144 K (+23.14 %) | |
| Sep 18 2019 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Grant | A | 0.00 | 27,048 | 0 | 145,997 | 118.9 K to 146 K (+22.74 %) | |
| Sep 18 2019 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Grant | A | 0.00 | 27,048 | 0 | 144,116 | 117.1 K to 144.1 K (+23.10 %) | |
| Sep 18 2019 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Grant | A | 0.00 | 27,048 | 0 | 102,378 | 75.3 K to 102.4 K (+35.91 %) | |
| Sep 18 2019 | TGTX | TG THERAPEUTICS, I ... | HUME DANIEL | Grant | A | 0.00 | 27,048 | 0 | 119,507 | 92.5 K to 119.5 K (+29.25 %) | |
| Jul 03 2019 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 8.47 | 17,654 | 149,529 | 383,338 | 401 K to 383.3 K (-4.40 %) |
| Jun 27 2019 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Buy | P | 7.04 | 50,000 | 351,750 | 12,878,185 | 12.8 M to 12.9 M (+0.39 %) |
| Jun 14 2019 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Grant | A | 0.00 | 1,179,380 | 0 | 12,828,185 | 11.6 M to 12.8 M (+10.12 %) |
| Jan 03 2019 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Option Exercise | A | 4.10 | 115,000 | 471,500 | 115,000 | |
| Jan 03 2019 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 4.13 | 37,275 | 153,946 | 400,992 | 438.3 K to 401 K (-8.51 %) |
| Jul 05 2018 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 13.19 | 35,000 | 461,650 | 438,267 | 473.3 K to 438.3 K (-7.40 %) |
| Jul 05 2018 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 13.26 | 12,191 | 161,653 | 473,267 | 485.5 K to 473.3 K (-2.51 %) |
| Jul 02 2018 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Grant | A | 0.00 | 15,000 | 0 | 118,949 | 103.9 K to 118.9 K (+14.43 %) | |
| Jun 28 2018 | TGTX | TG THERAPEUTICS, I ... | Hoberman Kenneth | Grant | A | 0.00 | 15,000 | 0 | 116,905 | 101.9 K to 116.9 K (+14.72 %) | |
| Jun 28 2018 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Grant | A | 0.00 | 15,000 | 0 | 75,330 | 60.3 K to 75.3 K (+24.86 %) | |
| Jun 28 2018 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Grant | A | 0.00 | 1,018,011 | 0 | 11,648,805 | 10.6 M to 11.6 M (+9.58 %) |
| Jun 28 2018 | TGTX | TG THERAPEUTICS, I ... | HUME DANIEL | Grant | A | 0.00 | 15,000 | 0 | 92,459 | 77.5 K to 92.5 K (+19.37 %) | |
| Jun 28 2018 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Grant | A | 0.00 | 15,000 | 0 | 117,068 | 102.1 K to 117.1 K (+14.70 %) | |
| Jun 28 2018 | TGTX | TG THERAPEUTICS, I ... | SCHOENEBAUM MARK | Grant | A | 0.00 | 15,000 | 0 | 125,949 | 110.9 K to 125.9 K (+13.52 %) | |
| Jun 18 2018 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Sell | S | 13.45 | 25,071 | 337,205 | 60,330 | 85.4 K to 60.3 K (-29.36 %) | |
| Jan 03 2018 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 8.50 | 32,006 | 272,051 | 485,458 | 517.5 K to 485.5 K (-6.19 %) |
| Jan 03 2018 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 70,000 | 0 | 517,464 | 447.5 K to 517.5 K (+15.64 %) |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Grant | A | 0.00 | 834,877 | 0 | 10,630,794 | 9.8 M to 10.6 M (+8.52 %) |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Gift | G | 0.00 | 350,000 | 0 | 9,795,917 | 10.1 M to 9.8 M (-3.45 %) |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Grant | A | 0.00 | 15,000 | 0 | 85,401 | 70.4 K to 85.4 K (+21.31 %) | |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Grant | A | 0.00 | 15,000 | 0 | 103,949 | 88.9 K to 103.9 K (+16.86 %) | |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | Hoberman Kenneth | Grant | A | 0.00 | 15,000 | 0 | 101,905 | 86.9 K to 101.9 K (+17.26 %) | |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | HUME DANIEL | Grant | A | 0.00 | 15,000 | 0 | 77,459 | 62.5 K to 77.5 K (+24.02 %) | |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Grant | A | 0.00 | 15,000 | 0 | 102,068 | 87.1 K to 102.1 K (+17.23 %) | |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | SCHOENEBAUM MARK | Grant | A | 0.00 | 15,000 | 0 | 110,949 | 95.9 K to 110.9 K (+15.63 %) | |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 11.04 | 30,000 | 331,200 | 447,464 | 477.5 K to 447.5 K (-6.28 %) |
| Jun 19 2017 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 11.14 | 29,976 | 333,933 | 477,464 | 507.4 K to 477.5 K (-5.91 %) |
| Apr 12 2017 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Sell | S | 10.27 | 8,548 | 87,788 | 70,401 | 78.9 K to 70.4 K (-10.83 %) | |
| Jan 04 2017 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 4.55 | 8,816 | 40,113 | 507,440 | 516.3 K to 507.4 K (-1.71 %) |
| Jan 04 2017 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 100,000 | 0 | 516,256 | 416.3 K to 516.3 K (+24.02 %) |
| Jan 04 2017 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Grant | A | 0.00 | 693,750 | 0 | 10,145,917 | 9.5 M to 10.1 M (+7.34 %) |
| Jan 04 2017 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Grant | A | 0.00 | 418,371 | 0 | 9,452,167 | 9 M to 9.5 M (+4.63 %) |
| Jan 04 2017 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Grant | A | 0.00 | 2,960,000 | 0 | 9,033,796 | 6.1 M to 9 M (+48.73 %) |
| Jan 04 2017 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | CEO and President | Sell | D | 0.00 | 3,381,866 | 0 | 6,073,796 | 9.5 M to 6.1 M (-35.77 %) |
| Sep 01 2016 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Gift | G | 0.00 | 328,764 | 0 | 9,455,662 | 9.8 M to 9.5 M (-3.36 %) |
| Jul 08 2016 | TGTX | TG THERAPEUTICS, I ... | Hoberman Kenneth | Director | Grant | A | 0.00 | 12,459 | 0 | 86,905 | 74.4 K to 86.9 K (+16.74 %) |
| Jul 08 2016 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 5.99 | 50,426 | 302,052 | 416,256 | 466.7 K to 416.3 K (-10.81 %) |
| Jul 08 2016 | TGTX | TG THERAPEUTICS, I ... | HUME DANIEL | Director | Grant | A | 0.00 | 12,459 | 0 | 62,459 | 50 K to 62.5 K (+24.92 %) |
| Jul 08 2016 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Director | Grant | A | 0.00 | 12,459 | 0 | 87,068 | 74.6 K to 87.1 K (+16.70 %) |
| Jul 08 2016 | TGTX | TG THERAPEUTICS, I ... | SCHOENEBAUM MARK | Director | Grant | A | 0.00 | 12,459 | 0 | 95,949 | 83.5 K to 95.9 K (+14.92 %) |
| Jul 08 2016 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Grant | A | 0.00 | 12,459 | 0 | 78,949 | 66.5 K to 78.9 K (+18.74 %) |
| Jul 08 2016 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 12,459 | 0 | 95,949 | 83.5 K to 95.9 K (+14.92 %) |
| Apr 20 2016 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 10.12 | 10,000 | 101,200 | 466,682 | 476.7 K to 466.7 K (-2.10 %) |
| Jan 07 2016 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 11.21 | 22,790 | 255,476 | 476,682 | 499.5 K to 476.7 K (-4.56 %) |
| Jan 04 2016 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 50,000 | 0 | 499,472 | 449.5 K to 499.5 K (+11.12 %) |
| Jan 04 2016 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Grant | A | 0.00 | 6,723,443 | 0 | 9,398,976 | 2.7 M to 9.4 M (+251.29 %) |
| Jul 09 2015 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Sell | S | 17.08 | 17,000 | 290,360 | 66,490 | 83.5 K to 66.5 K (-20.36 %) |
| Jul 02 2015 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 16.46 | 50,054 | 823,889 | 449,472 | 499.5 K to 449.5 K (-10.02 %) |
| Jun 08 2015 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Director | Grant | A | 0.00 | 4,667 | 0 | 74,609 | 69.9 K to 74.6 K (+6.67 %) |
| Jun 05 2015 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Grant | A | 0.00 | 4,667 | 0 | 83,490 | 78.8 K to 83.5 K (+5.92 %) |
| Jun 05 2015 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 4,667 | 0 | 83,490 | 78.8 K to 83.5 K (+5.92 %) |
| Jun 05 2015 | TGTX | TG THERAPEUTICS, I ... | SCHOENEBAUM MARK | Director | Grant | A | 0.00 | 4,667 | 0 | 83,490 | 78.8 K to 83.5 K (+5.92 %) |
| Jun 05 2015 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Grant | A | 0.00 | 337,257 | 0 | 8,726,633 | 8.4 M to 8.7 M (+4.02 %) |
| Jun 05 2015 | TGTX | TG THERAPEUTICS, I ... | Hoberman Kenneth | Director | Grant | A | 0.00 | 4,667 | 0 | 74,446 | 69.8 K to 74.4 K (+6.69 %) |
| May 11 2015 | TGTX | TG THERAPEUTICS, I ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Option Exercise | X | 0.00 | 2,500,000 | 2,500 | 0 | |
| May 11 2015 | TGTX | TG THERAPEUTICS, I ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Buy | X | 0.00 | 2,500,000 | 2,500 | 7,614,855 | 5.1 M to 7.6 M (+48.88 %) |
| May 11 2015 | TGTX | TG THERAPEUTICS, I ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Buy | P | 6.53 | 114,855 | 750,003 | 5,114,855 | 5 M to 5.1 M (+2.30 %) |
| Apr 03 2015 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 15.51 | 11,000 | 170,610 | 499,526 | 510.5 K to 499.5 K (-2.15 %) |
| Apr 03 2015 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 15.50 | 12,800 | 198,400 | 510,526 | 523.3 K to 510.5 K (-2.45 %) |
| Jan 07 2015 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 16.40 | 12,344 | 202,442 | 523,326 | 535.7 K to 523.3 K (-2.30 %) |
| Jan 07 2015 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 16.40 | 54,057 | 886,448 | 535,670 | 589.7 K to 535.7 K (-9.17 %) |
| Jan 02 2015 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 10,000 | 0 | 589,727 | 579.7 K to 589.7 K (+1.72 %) |
| Jan 02 2015 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Grant | A | 0.00 | 268,603 | 0 | 8,389,376 | 8.1 M to 8.4 M (+3.31 %) |
| Dec 18 2014 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Sell | S | 16.44 | 210,618 | 3,462,560 | 8,120,773 | 8.3 M to 8.1 M (-2.53 %) |
| Dec 18 2014 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Sell | S | 16.44 | 38,041 | 625,394 | 579,727 | 617.8 K to 579.7 K (-6.16 %) |
| Jun 10 2014 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Director | Grant | A | 0.00 | 11,538 | 0 | 69,942 | 58.4 K to 69.9 K (+19.76 %) |
| Jun 10 2014 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 11,538 | 0 | 78,823 | 67.3 K to 78.8 K (+17.15 %) |
| Jun 10 2014 | TGTX | TG THERAPEUTICS, I ... | SCHOENEBAUM MARK | Director | Grant | A | 0.00 | 11,538 | 0 | 78,823 | 67.3 K to 78.8 K (+17.15 %) |
| Jun 10 2014 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Grant | A | 0.00 | 11,538 | 0 | 80,088 | 68.6 K to 80.1 K (+16.83 %) |
| Jun 10 2014 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Grant | A | 0.00 | 11,538 | 0 | 78,823 | 67.3 K to 78.8 K (+17.15 %) |
| Jan 02 2014 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Grant | A | 0.00 | 491,920 | 0 | 8,331,391 | 7.8 M to 8.3 M (+6.27 %) |
| Jan 02 2014 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 75,000 | 0 | 617,768 | 542.8 K to 617.8 K (+13.82 %) |
| Jan 02 2014 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Payment of Exercise | F | 5.38 | 23,106 | 124,310 | 542,768 | 565.9 K to 542.8 K (-4.08 %) |
| Dec 12 2013 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Buy | P | 3.43 | 10,000 | 34,300 | 7,839,471 | 7.8 M to 7.8 M (+0.13 %) |
| Jun 07 2013 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Director | Grant | A | 0.00 | 8,404 | 0 | 58,404 | 50 K to 58.4 K (+16.81 %) |
| Jun 07 2013 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Grant | A | 0.00 | 8,404 | 0 | 68,550 | 60.1 K to 68.6 K (+13.97 %) |
| Jun 07 2013 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Grant | A | 0.00 | 8,404 | 0 | 67,285 | 58.9 K to 67.3 K (+14.27 %) |
| Jun 07 2013 | TGTX | TG THERAPEUTICS, I ... | SCHOENEBAUM MARK | Director | Grant | A | 0.00 | 8,404 | 0 | 67,285 | 58.9 K to 67.3 K (+14.27 %) |
| Jun 07 2013 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 8,404 | 0 | 67,285 | 58.9 K to 67.3 K (+14.27 %) |
| Mar 19 2013 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 8,881 | 0 | 58,881 | 50 K to 58.9 K (+17.76 %) |
| Mar 19 2013 | TGTX | TG THERAPEUTICS, I ... | SCHOENEBAUM MARK | Director | Grant | A | 0.00 | 8,881 | 0 | 58,881 | 50 K to 58.9 K (+17.76 %) |
| Mar 19 2013 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Grant | A | 0.00 | 8,881 | 0 | 58,881 | 50 K to 58.9 K (+17.76 %) |
| Mar 19 2013 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Grant | A | 0.00 | 8,881 | 0 | 60,146 | 51.3 K to 60.1 K (+17.32 %) |
| Mar 19 2013 | TGTX | TG THERAPEUTICS, I ... | Echelard Yann | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Jan 02 2013 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | Chairman, Interim C ... | Grant | A | 0.00 | 86,743 | 0 | 7,829,471 | 7.7 M to 7.8 M (+1.12 %) |
| Jan 02 2013 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | Chairman, Interim C ... | Grant | A | 0.00 | 400,000 | 0 | 7,742,728 | 7.3 M to 7.7 M (+5.45 %) |
| Jan 02 2013 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 75,000 | 0 | 565,874 | 490.9 K to 565.9 K (+15.28 %) |
| Jan 02 2013 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Payment of Exercise | F | 6.25 | 13,526 | 84,538 | 490,874 | 504.4 K to 490.9 K (-2.68 %) |
| Dec 12 2012 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Buy | P | 2.00 | 1,000 | 2,000 | 51,265 | 50.3 K to 51.3 K (+1.99 %) |
| Sep 17 2012 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Buy | P | 2.28 | 3,400 | 7,752 | 504,400 | 501 K to 504.4 K (+0.68 %) |
| Sep 17 2012 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Buy | P | 2.25 | 1,000 | 2,250 | 501,000 | 500 K to 501 K (+0.20 %) |
| Sep 11 2012 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Buy | P | 2.25 | 100,000 | 225,000 | 7,342,728 | 7.2 M to 7.3 M (+1.38 %) |
| Sep 11 2012 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Buy | P | 2.25 | 50,000 | 112,500 | 7,242,728 | 7.2 M to 7.2 M (+0.70 %) |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Option Exercise | C | 0.00 | 396,513 | 0 | 0 | |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Buy | P | 6.25 | 1,500 | 9,375 | 5,192,728 | 5.2 M to 5.2 M (+0.03 %) |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Grant | A | 0.00 | 1,500,000 | 0 | 5,191,228 | 3.7 M to 5.2 M (+40.64 %) |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | WEISS MICHAEL S | See Remarks | Buy | C | 0.00 | 3,524,560 | 0 | 3,691,228 | 166.7 K to 3.7 M (+2,114.72 %) |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Option Exercise | C | 0.00 | 16,875 | 0 | 0 | |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Grant | A | 0.00 | 350,000 | 0 | 500,000 | 150 K to 500 K (+233.33 %) |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | Power Sean A | CFO, Secretary and ... | Buy | C | 0.00 | 150,000 | 0 | 150,000 | 0 to 150 K |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Grant | A | 0.00 | 50,000 | 0 | 50,265 | 265 to 50.3 K (+18,867.92 %) |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | Charney Laurence N | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | SCHOENEBAUM MARK | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| May 17 2012 | TGTX | TG THERAPEUTICS, I ... | KENNEDY WILLIAM JAMES | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Mar 22 2010 | TGTX | TG THERAPEUTICS, I ... | Shimko David | Director | Option Exercise | A | 0.08 | 50,000 | 3,750 | 50,000 | |
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | Steinhart Richard I | Director | Option Exercise | A | 0.07 | 300,000 | 21,000 | 300,000 | |
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Option Exercise | A | 0.07 | 300,000 | 21,000 | 300,000 | |
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Buy | J | 0.00 | 61,663 | 0 | 138,951 | 77.3 K to 139 K (+79.78 %) |
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | WEISER MICHAEL | Option Exercise | A | 0.07 | 250,000 | 17,500 | 250,000 | ||
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | WEISER MICHAEL | Buy | J | 0.00 | 44,678 | 0 | 2,292,241 | 2.2 M to 2.3 M (+1.99 %) | |
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | McGuinness Michael | COO & CFO | Option Exercise | A | 0.07 | 2,000,000 | 140,000 | 2,000,000 | |
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | Hoenlein Malcolm | Option Exercise | A | 0.07 | 250,000 | 17,500 | 250,000 | ||
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | ABEL DOUGLAS | Director | Option Exercise | A | 0.07 | 50,000 | 3,500 | 50,000 | |
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | MCINERNEY TIMOTHY | Director | Option Exercise | A | 0.07 | 300,000 | 21,000 | 300,000 | |
| Mar 10 2010 | TGTX | TG THERAPEUTICS, I ... | MCINERNEY TIMOTHY | Director | Buy | J | 0.00 | 6,347 | 0 | 674,007 | 667.7 K to 674 K (+0.95 %) |
| Sep 15 2008 | TGTX | TG THERAPEUTICS, I ... | WEISER MICHAEL | Director | Option Exercise | A | 0.20 | 24,000 | 4,800 | 24,000 | |
| Sep 15 2008 | TGTX | TG THERAPEUTICS, I ... | MCINERNEY TIMOTHY | Director | Option Exercise | A | 0.20 | 24,000 | 4,800 | 24,000 | |
| Sep 15 2008 | TGTX | TG THERAPEUTICS, I ... | McGuinness Michael | Chief Financial Off ... | Option Exercise | A | 0.20 | 24,000 | 4,800 | 24,000 | |
| Sep 15 2008 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Option Exercise | A | 0.20 | 24,000 | 4,800 | 24,000 | |
| Sep 15 2008 | TGTX | TG THERAPEUTICS, I ... | ABEL DOUGLAS | President and CEO | Option Exercise | A | 0.20 | 24,000 | 4,800 | 24,000 | |
| Mar 28 2008 | TGTX | TG THERAPEUTICS, I ... | MCINERNEY TIMOTHY | Director | Option Exercise | A | 0.17 | 75,000 | 12,750 | 75,000 | |
| Mar 28 2008 | TGTX | TG THERAPEUTICS, I ... | Steinhart Richard I | Director | Option Exercise | A | 0.17 | 75,000 | 12,750 | 75,000 | |
| Mar 28 2008 | TGTX | TG THERAPEUTICS, I ... | ABEL DOUGLAS | President and CEO | Option Exercise | A | 0.17 | 1,300,000 | 221,000 | 1,300,000 | |
| Mar 28 2008 | TGTX | TG THERAPEUTICS, I ... | Herskowitz Neil | Director | Option Exercise | A | 0.17 | 75,000 | 12,750 | 75,000 | |
| Mar 28 2008 | TGTX | TG THERAPEUTICS, I ... | McGuinness Michael | Chief Financial Off ... | Option Exercise | A | 0.17 | 1,100,000 | 187,000 | 1,100,000 | |
| Mar 28 2008 | TGTX | TG THERAPEUTICS, I ... | WEISER MICHAEL | Director | Option Exercise | A | 0.17 | 75,000 | 12,750 | 75,000 | |
| Mar 28 2008 | TGTX | TG THERAPEUTICS, I ... | Hoenlein Malcolm | Director | Option Exercise | A | 0.17 | 75,000 | 12,750 | 75,000 | |
| Aug 02 2007 | TGTX | TG THERAPEUTICS, I ... | ABEL DOUGLAS | Chief Executive Off ... | Grant | A | 0.27 | 10,000 | 2,650 | 45,000 | 35 K to 45 K (+28.57 %) |
| Aug 02 2007 | TGTX | TG THERAPEUTICS, I ... | WEISER MICHAEL | Director | Grant | A | 0.26 | 10,000 | 2,600 | 2,247,563 | 2.2 M to 2.2 M (+0.45 %) |
| Jul 20 2007 | TGTX | TG THERAPEUTICS, I ... | ABEL DOUGLAS | President and CEO | Grant | A | 0.36 | 10,000 | 3,600 | 45,000 | 35 K to 45 K (+28.57 %) |